Skip to content

Electroacupuncture for infertile patients undergoing FET: a randomized controlled trial

Electroacupuncture for infertile patients undergoing FET: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092871
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

EA+HRT group:Electroacupuncture and Hormone Replacement Therapy intervention
sEA+HRT group:Sham electroacupuncture and Hormone Replacement Therapy intervention

Sponsors

Chengdu University of Traditional Chinese Medicine; Sichuan Jinxin Xinan Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1) Infertile patients undergoing FET, with previous transplantation cycles =2; 2) age: 21= age < 38; 3) at least one high-quality blastocyst or two high-quality cleavage embryos; 4) patients with hormone replacement cycle for endometrial preparation; 5) hysteroscopy examination was completed and the results were normal; 6) voluntarily sign informed consent; Note: Patients who met the above 6 criteria were included in this study.

Exclusion criteria

Exclusion criteria: 1) Those planning to undergo pre-implantation genetic testing (PGT); 2) Patients with uterine abnormalities (unicornuate uterus, bicornuate uterus, didelphic uterus, or untreated uterine septum) or other untreated diseases damaging the uterine cavity, such as adenomyosis, submucosal fibroids, uterine adhesions, or scarred uterus; 3) Those with uncorrected hyperprolactinemia, hyperandrogenism, thyroid dysfunction, or chronic adrenal insufficiency and other metabolic endocrine diseases; 4) Those with recurrent miscarriage; 5) Those with a tendency for bleeding or easy infection, severe allergies, or contraindications such as ulcers, and scars, and those prohibited from acupuncture; 6) patients who received acupuncture treatment in the past three months; 7) patients who are participating in other clinical trials. Note: Patients meeting any of the above criteria should be excluded.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;

Secondary

MeasureTime frame
Cycle cancellation rate;Biochemical pregnancy rate;Embryo implantation rate;Live birth rate;

Countries

China

Contacts

Public ContactJie Yang

Chengdu University of Traditional Chinese Medicine; Sichuan Jinxin Xinan Women's and Children's Hospital

jenny_yang_jie@126.com+86 138 8229 6714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026